Vaccinations have been completed and Valneva expects VALOR trial outcomes to be announced in the first half of 2026, followed by regulatory submissions as planned. Pfizer aims to submit a Biologics ...

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

Pfizer and Tris Pharma agreed to pay $41.5 million to settle allegations they altered testing methods to ensure their ADHD ...

Discover why Pfizer stock may be set for a bull run by 2026 with key wins, strong Q3 earnings, and growth drivers.

Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...

A wave of lawsuits with novel strategies show that the search for Covid vengeance — and jury awards — has gained force under ...

New details from health officials suggest the whooping cough surge may be part of a national pattern driven by slipping ...

Get the latest New Zealand national news now. Discover breaking news and in-depth coverage with videos and photos.

The German biopharmaceutical company BioNTech finds itself at a critical juncture following a significant divestment by its ...

COLUMBIA, S.C. — A South Carolina Senate Medical Affairs subcommittee heard more than an hour of conflicting testimony ...